Who Paid My Doc
Bio4
Device Bone Substitute
General payments
$479,365
Research payments
$30,875
Through program year 2025, $479,365 in general payments and $30,875 in research payments were reported against Bio4 (Bone Substitute).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $13,694 | 269 |
| 2024 | General | $39,114 | 288 |
| 2023 | General | $54,497 | 380 |
| 2022 | General | $85,843 | 643 |
| 2021 | General | $63,480 | 827 |
| 2021 | Research | $1,500 | 2 |
| 2020 | General | $90,831 | 686 |
| 2020 | Research | $22,875 | 2 |
| 2019 | General | $131,906 | 1,618 |
| 2019 | Research | $6,500 | 1 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 21 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 26 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
4,711 general · 5 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.